AFFINI-T THERAPEUTICS, INC.

Profile

Company Names

AFFINI-T THERAPEUTICS, INC.

Addresses

100 FORGE ROAD, SUITE 900, WATERTOWN, MA 02472

Phone Numbers

(617) 380-3737

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$17,617,952.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-07-31 
$17,617,952.00 
$17,617,952.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KATHY 
 
BERGSTEINSSON 
EXECUTIVE OFFICER
AFFINI-T THERAPEUTICS, INC.
JILL 
 
DESIMONE 
DIRECTOR
AFFINI-T THERAPEUTICS, INC.
DANIEL 
 
FAGA 
DIRECTOR
AFFINI-T THERAPEUTICS, INC.
ARJUN 
 
GOYAL 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  SCORPION THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  THIRD ARC BIO, INC.   |  HALDA THERAPEUTICS, LLC   |  AFFINI-T THERAPEUTICS, INC.
LUCIO 
 
IANNONE 
DIRECTOR
PYXIS ONCOLOGY, INC.   |  EGENESIS, INC.   |  AZITRA INC   |  IMMUNITAS THERAPEUTICS, INC.   |  DEKA BIOSCIENCES, INC.   |  AFFINI-T THERAPEUTICS, INC.
JOSEPH 
 
KNOWLES 
EXECUTIVE OFFICER, DIRECTOR
AFFINI-T THERAPEUTICS, INC.
MICHAEL 
 
VARNEY 
DIRECTOR
INTERLINE THERAPEUTICS, INC.   |  AFFINI-T THERAPEUTICS, INC.
KATHY 
 
YI 
EXECUTIVE OFFICER
TRANSITION BIO, INC.   |  AFFINI-T THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#